蘋果(AAPL.US)及戴爾(DELL.US)主要供應商和碩聯合稱美國設廠計劃正處最後評估階段
蘋果(AAPL.US)及戴爾(DELL.US)主要供應商和碩聯合(Pegatron)總經理暨執行長鄭光志表示,美國設廠計劃正處於最後評估階段,公司將於本月或下月公布最終決定。他指公司考慮的關鍵因素包括土地和勞動成本,其中電力成本是人工智能伺服器生產中最關鍵因素。
他又表示,公司去年開始在墨西哥規劃人工智能伺服器生產線,預計第三季度將開始量產。
公司自美國總統特朗普第一任期以來已開始將製造基地從中國擴展到東南亞及墨西哥。公司在美國印第安納州設有維修基地,在加州設有辦事處。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.